| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
O'Brien Anthony Stephen serves as a Director at EVFM. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $66 at current prices.
The biggest single holding is EVFM (~$66) as Director. Net of sales, the recent Form 4 record there shows accumulation of 8,140 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2021 | EVFM Evofem Biosciences, Inc. | Director | Buy | 8,140 | $1.31 | $10,663.40 | New |